Global /Israel /Healthcare /Biotechnology /DNA
chevron_leftBack
Israel Canada Hotels Ltd. logo

Israel Canada Hotels Ltd.

DNA
• TLV: DNA • Delayed
107ILA -0.8%
0.3703 USD
As of 5 June 2026, Israel Canada Hotels Ltd. has a market cap of $335.01M USD, ranking #17906 globally and #236 in Israel. It ranks #1626 in the Healthcare sector, and #312 in the Biotechnology industry.
Global Rank
17906
Country Rank
236
Sector Rank
1626
Industry Rank
312
Key Stats
Market Cap
$335.01MUSD
962.09M ILS
Enterprise Value
$308.36MUSD
891.76M ILS
Revenue (TTM)
$106.55KUSD
306.0K ILS
Net Income (TTM)
$179.68KUSD
516.0K ILS
Profit Margin
169%
PE Ratio
267.3
PS Ratio
3144.1
PB Ratio
9.8
Company Profile
Country (HQ)
Israel
Sector
Healthcare
Industry
Biotechnology
CEO
Erez Navon open_in_new
Founded
2004
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-0.8% 2.6% 18% -7.6% -17% 4.8%

News

Loading...

Markets

Exchange Ticker Price
Tel Aviv Stock Exchange
MIC: XTAE
PRIMARY
DNA
קבוצת די.אן.איי. (ט.ר) בעמ
ISIN: IL0011038523
Shares Out.:
830.15M1 Shares Float: 502.326M2
TV:
TASE: DNA
SA:
TLV: DNA
YF:
DNA.TA
GF:
TLV: DNA
BA:
DNA
MS:
XTAE: DNA
107 ILA
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Israel Canada Hotels Ltd.

Israel Canada Hotels Ltd, together with its subsidiaries, engages in the development, manufacturing, and marketing of patented ultrasound systems in Israel, North America, East Asia, and internationally. The company provides systems for diagnosing bone strength and density, as well as for monitoring calcium leakage (osteoporosis) in adults and children. It also engages in the development of oral drugs. The company was formerly known as Dna Group (T.R.) Ltd and changed its name to Israel Canada Hotels Ltd in November 2025. Israel Canada Hotels Ltd was incorporated in 2004 and is based in Tel Aviv-Yafo, Israel.

Similar Companies

Industry: Biotechnology (Israel)
Name
Market Cap diff.
PE
Kamada Ltd.
KMDA
$470.55M
40%
23.3
Compugen Ltd.
CGEN
$245.84M
-27%
6.9
Enlivex Ltd.
ENLV
$190.26M
-43%
0.0
Kadimastem Ltd.
KDST
$56.08M
161.06M ILS
-83%
-
Pluri Inc.
PLUR
$34.07M
-90%
-
Polyrizon Ltd.
PLRZ
$28.03M
-92%
-
Industry: Biotechnology (Global)
Name
Market Cap diff.
PE
Amgen Inc.
AMGN
$182.42B
54K%
23.9
Gilead Sciences, Inc.
GILD
$159.92B
48K%
19.0
argenx SE
ARGX
$48.01B
41.39B EUR
14K%
39.9
Samsung Biologics Co.,Ltd.
207940
$44.36B
68.19T KRW
13K%
35.5
CSL Ltd.
CSL
$42.98B
60.27B AUD
13K%
29.3
Lonza Group AG
LONN
$42.55B
33.71B CHF
13K%
37.2
chevron_leftBack